ConductScience.org, home

Paper38672011

The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.

Lungu PF and 8 others. Brain Sci, 2024. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review. Papers, record 38672011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38672011

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.
PubMed
Journal
Brain Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.36, provisional
iCite
Revised in PubMed
2024-04-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lungu PFPetru Fabian
2Lungu CMCorina Mirunahttps://orcid.org/0009-0007-8267-6977
3Ciobica AAlin
4Balmus IMIoana Miruna
5Vitalaru RRaluca
6Mavroudis IIoannishttps://orcid.org/0000-0001-9844-4010
7Dobrin RRomeohttps://orcid.org/0000-0003-3023-0205
8Cimpeanu MMirela
9Gurzu ILIrina Lucianahttps://orcid.org/0000-0003-3095-3497

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17,559,378Antipsychotic effect of cannabidiol.J Clin Psychiatry1995https://conductscience.org/library/papers/7559378PubMed
232,141,723Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.J Clin Psychiatry2020https://conductscience.org/library/papers/32141723PubMed
39,090,333Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.Am J Psychiatry1997https://conductscience.org/library/papers/9090333PubMed
416,793,238Antipsychotic medication and cognitive function in schizophrenia.Schizophr Res2006https://conductscience.org/library/papers/16793238PubMed
515,784,157A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.Int J Neuropsychopharmacol2005https://conductscience.org/library/papers/15784157PubMed
62,602,512The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.Psychopharmacol Bull1989https://conductscience.org/library/papers/2602512PubMed
717,548,746Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.Arch Gen Psychiatry2007https://conductscience.org/library/papers/17548746PubMed
829,413,518Unique Effects of Clozapine: A Pharmacological Perspective.Adv Pharmacol2018https://conductscience.org/library/papers/29413518PubMed
910,416,729The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.Schizophr Bull1999https://conductscience.org/library/papers/10416729PubMed
1027,267,317Could cannabidiol be used as an alternative to antipsychotics?J Psychiatr Res2016https://conductscience.org/library/papers/27267317PubMed
1115,205,874Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders.Psychopharmacology (Berl)2004https://conductscience.org/library/papers/15205874PubMed
1222,795,368Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis.Schizophr Res2012https://conductscience.org/library/papers/22795368PubMed
1317,163,083Screening for dementia in community-based memory clinics.WMJ2006https://conductscience.org/library/papers/17163083PubMed
147,323,768The epidemiology of paranoid schizophrenia.Schizophr Bull1981https://conductscience.org/library/papers/7323768PubMed
1514,702,259Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.Am J Psychiatry2004https://conductscience.org/library/papers/14702259PubMed
1611,470,207
Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
J Pharm Biomed Anal2001https://conductscience.org/library/papers/11470207PubMed
1722,193,671The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.Am J Psychiatry2011https://conductscience.org/library/papers/22193671PubMed
1824,145,817Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis.Eur J Clin Pharmacol2014https://conductscience.org/library/papers/24145817PubMed
1918,801,821Cannabidiol for the treatment of psychosis in Parkinson's disease.J Psychopharmacol2009https://conductscience.org/library/papers/18801821PubMed
2024,648,768Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.Drug Healthc Patient Saf2014https://conductscience.org/library/papers/24648768PubMed

See all 111 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41,530,321Reduced categorical congruence of cognitive and affective empathy in persons with psychotic disorders.Sci Rep2026https://conductscience.org/library/papers/41530321PubMed
41,211,592Comparison of ziprasidone and olanzapine on cognitive function in patients with schizophrenia at different stages: a prospective study in Huai'an, China.Front Behav Neurosci2025https://conductscience.org/library/papers/41211592PubMed
41,155,663Preliminary Data Regarding the Alleviating Effects of Haloperidol and Risperidone on the Short-Term Memory and Associative Learning in a Zebrafish Model of Schizophrenia.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155663PubMed
40,859,289Cognitive impairment and its influencing factors in patients with stable schizophrenia on regular medication: a real-world clinical study.BMC Psychiatry2025https://conductscience.org/library/papers/40859289PubMed
40,830,229Neurobehavioral profile of individuals with pathogenic variants in CHD3.Eur J Hum Genet2025https://conductscience.org/library/papers/40830229PubMed
40,817,421Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database.Int J Geriatr Psychiatry2025https://conductscience.org/library/papers/40817421PubMed
38,891,871D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside.Int J Mol Sci2024https://conductscience.org/library/papers/38891871PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38672011

GET https://conductscience.org/api/papers/v1/38672011/references?page=2